Immunologically active proteins in intravenous immunoglobulin
Authors:
- Lee LamLLLee Lam
- CarolynF. WhitsettCWCarolynF. Whitsett
- JanetM. McNichollJMJanetM. McNicholl
- ThomasW. HodgeTHThomasW. Hodge
- John HooperJHJohn Hooper
- 1 September 1993
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 342 (8872) , 678
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparationsThe Lancet, 1993
- Soluble HLA class I and class II concentrations in commercial immunoglobuh preparationsTissue Antigens, 1992
- The Use of Intravenous Immune Globulin in Immunodeficiency DiseasesNew England Journal of Medicine, 1991
- Are soluble monocyte-derived HLA class II molecules candidates for immunosuppressive activity?Immunology Letters, 1990
- Intravenous immunoglobulin therapy in systemic lupus erythematosus‐associated thrombocytopeniaArthritis & Rheumatism, 1990
- Autoantibodies to cytokines - friends or foes?Immunology Today, 1990